Graph not available
Graph not available

Open Demat Account

50years
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
left-arrow
Fundamentals
Financials
Shareholding
Resistance/Support
Delivery and Volume
About
Management
News
Similar Stocks
right-arrow

Biogen Pharmachem Industries Ltd Fundamentals

Market Cap
₹ 74.4 Cr
P/E Ratio (TTM)
38.00
P/B Ratio
1.32
Debt to Equity
0.00
ROE
-0.34
EPS (TTM)
0.03
Dividend Yield
0.00 %
Book Value
0.87

Click here to know more about Fundamentals

Biogen Pharmachem Industries Ltd Financials

Biogen Pharmachem Industries Ltd Financials

Biogen Pharmachem Industries Ltd Shareholding Pattern

Held By Mar 2024 Dec 2023 Sep 2023 Jun 2023
Retail 76.85 % 76.85 % 76.85 % 76.85 %
Others 23.15 % 23.15 % 23.15 % 23.15 %
Mutual Funds 0.00 % 0.00 % 0.00 % 0.00 %
FII 0.00 % 0.00 % 0.00 % 0.00 %
Promoters 0.00 % 0.00 % 0.00 % 0.00 %

Retail

76.85%

Others

23.15%

Mutual Funds

0.00%

FII

0.00%

Promoters

0.00%

Retail

76.85%

Others

23.15%

Mutual Funds

0.00%

FII

0.00%

Promoters

0.00%

Retail

76.85%

Others

23.15%

Mutual Funds

0.00%

FII

0.00%

Promoters

0.00%

Retail

76.85%

Others

23.15%

Mutual Funds

0.00%

FII

0.00%

Promoters

0.00%

Resistance and Support

₹1.13

PIVOT

resistance-arrow
Resistance
First Resistance₹1.157
Second Resistance₹1.173
Third Resistance₹1.197
support-arrow
Support
First Support₹1.117
Second Support₹1.093
Third Support₹1.077

Delivery and Volume

PeriodDelivery Volume Traded Volume Delivery Volume %
Day2,456,9421,849,71375.29
Week4,208,4201,654,3400.00
1 Month4,208,4201,689,0050.00
6 Months398,322,516351,201,51286.62

About Biogen Pharmachem Industries Ltd

Biogen Pharmachem Industries Ltd was formerly incorporated as Wellworth Overseas Limited in July, 1995. The name of the Company was changed to Sun Techno Overseas Limited in August 2011 and again the name got changed from Sun Techno Overseas Limited to Biogen Pharmachem Industries Limited on March 24,2021. The Company is engaged in the business of trading in shares and securities in present and future market. It trades in commodities, including agro based and precious metals, and other goods. The company also provides stock broking and consulting services. In addition, it generates, trades, and sells wind power. As of March 31, 2009, the Company had started trading operations and business in commodities, both in agro-based and precious metals, and other goods in present and future markets. During the fiscal year ended March 31, 2009 (fiscal 2009), the Company was exploring opportinuities to do the business of import, export and trading in gold, silver and other precious metals, including diamond. The Company is also diversifying its business activities in the power sector, by establishing wind power generation plant. Company has changed its main objects to Pharmaceutical company dated 8th March 2021.

Managing Director

NA

Founded

1995

NSE Symbol

NA

Biogen Pharmachem Industries Ltd Management

NameDesignation
Niraj VaghelaChairman & WTD & CFO
Chandrakant Govingbhai ParmarIndependent Director
Khushboo KhandelwalCompany Sec. & Compli. Officer
Harshadkumar RathodDirector
Narendrakumar VaniyaDirector
Komalben ChauhanDirector
CHHAYA PARMARNon Executive Director

Biogen Pharmachem Industries Ltd News

Biogen Pharmachem Industries reports standalone net profit of Rs 0.74 crore in the March 2024 quarter
Reported sales nil
Biogen Pharmachem Industries to discuss results
On 25 May 2024
Biogen Pharmachem Industries standalone net profit declines 80.00% in the December 2023 quarter
Reported sales nil
Biogen Pharmachem Industries announces board meeting date
On 22 January 2024
Biogen Pharmachem Industries to conduct board meeting
On 9 January 2024
Biogen Pharmachem Industries standalone net profit declines 62.89% in the September 2023 quarter
Reported sales nil
Biogen Pharmachem Industries to hold board meeting
On 1 November 2023
Biogen Pharmachem Industries schedules AGM
On 30 September 2023
Biogen Pharmachem Industries reports standalone net profit of Rs 0.41 crore in the June 2023 quarter
Reported sales nil
Biogen Pharmachem Industries to table results
On 10 August 2023

Similar Stocks

CompanyMarket CapMarket PriceP/E Ratio
Bajaj Finance Ltd₹ 451375.21 Cr
₹ 7,292.05
(1.00 %)
35.70
Bajaj Finserv Ltd₹ 253893.22 Cr
₹ 1,590.15
(0.68 %)
216.94
Jio Financial Services Ltd₹ 229226.49 Cr
₹ 360.80
(-0.03 %)
0.00
Indian Railway Finance Corporation Ltd₹ 228894.88 Cr
₹ 175.15
(-1.46 %)
35.67
Power Finance Corporation Ltd₹ 166176.62 Cr
₹ 503.55
(2.41 %)
11.57

Biogen Pharmachem Industries Ltd FAQ

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Biogen Pharmachem Industries Ltd shares in BlinkX

Biogen Pharmachem Industries Ltd's P/E ratio is 38.00 times as of June 13, 2024 at 04:00 PM.

Biogen Pharmachem Industries Ltd's most recent financial reports indicate a price-to-book ratio of 1.32, showing the company's stock market valuation in relation to the value of its real assets.

Market capitalisation, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Biogen Pharmachem Industries Ltd's market is 74 Cr as on June 13, 2024 at 04:00 PM.

The current financial records of Biogen Pharmachem Industries Ltd show a -0.34% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

According to Biogen Pharmachem Industries Ltd's most recent financial filings, the company has a total asset value of Crores, which includes current and non-current assets such as inventory, cash, properties, and equipment.

As of the Mar 2024 quarter, the promoter shareholding in Biogen Pharmachem Industries Ltd stands at 0.00%. During the same period, Institutional Investors have shown a slight values are equal in their holdings, values are equal from 0.00% to 0.00%.